<bill session="119" type="h" number="661" updated="2025-04-02T19:45:46Z">
  <state datetime="2025-01-23">REFERRED</state>
  <status>
    <introduced datetime="2025-01-23"/>
  </status>
  <introduced datetime="2025-01-23"/>
  <titles>
    <title type="display">MIRACLE Medical Technology Act of 2025</title>
    <title type="short" as="introduced">Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025</title>
    <title type="short" as="introduced">MIRACLE Medical Technology Act of 2025</title>
    <title type="official" as="introduced">To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare &amp; Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.</title>
  </titles>
  <sponsor bioguide_id="B001260"/>
  <cosponsors>
    <cosponsor bioguide_id="M001215" joined="2025-01-23"/>
    <cosponsor bioguide_id="S001200" joined="2025-01-23"/>
  </cosponsors>
  <actions>
    <action datetime="2025-01-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-01-23" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Advisory bodies"/>
    <term name="Diplomacy, foreign officials, Americans abroad"/>
    <term name="Employment and training programs"/>
    <term name="Health promotion and preventive care"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Intellectual property"/>
    <term name="Israel"/>
    <term name="Manufacturing"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Public-private cooperation"/>
  </subjects>
  <amendments/>
  <summary date="2025-04-02T19:44:52Z" status="Introduced in House">Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025

This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes&#160;HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program&#226;&#8364;&#8482;s purposes.</summary>
</bill>
